Bacillus anthracis is an important human pathogen and a potential biological weapon. Drug therapy is available to treat B. anthracis infections since most strains are usually antibiotic sensitive. However, the possibility that bioterrorists may introduce drug resistance plasmids into B. anthracis to generate """"""""super bioterror agents"""""""", or such plasmids may transfer naturally into B. anthracis cannot be discounted. Therefore, it is important to identify new drug targets for this organism. PcrA is an essential helicase in Gram-positive bacteria, but its precise function(s) are not known. Gene knock-out experiments will be carried out to confirm that inactivation of the pcrA gene is lethal for B. anthracis. Biochemical studies will be carried out using purified PcrA helicase from B. anthracis to study its role in cellular DNA metabolism. Using substrates that represent DNA molecules that are intermediates in processes such as DNA replication, recombination and repair, we plan to study the DNA binding and helicase activities of PcrA. These studies will reveal whether PcrA is involved in the processing of the Okazaki fragments during DNA replication, and whether it is an editing helicase for the resolution of toxic recombination intermediates. We will carry out experiments to test whether PcrA can block the formation of recombination intermediates such as D-loop and whether it can displace the RecA protein bound to single-stranded DNA. We will also carry out genetic experiments to test whether PcrA is required for the replication of the pXO1 and pXO2 virulence plasmids of B. anthracis. Future development of drugs that specifically inhibit the functions of the PcrA helicase could add to the treatment regimen against B. anthracis and related organisms. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI064941-01A1
Application #
7039308
Study Section
Special Emphasis Panel (ZRG1-IDM-A (90))
Program Officer
Breen, Joseph J
Project Start
2006-02-01
Project End
2008-01-31
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
1
Fiscal Year
2006
Total Cost
$222,750
Indirect Cost
Name
University of Pittsburgh
Department
Genetics
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Leuba, Sanford H; Anand, Syam P; Harp, Joel M et al. (2008) Expedient placement of two fluorescent dyes for investigating dynamic DNA protein interactions in real time. Chromosome Res 16:451-67
Anand, Syam P; Zheng, Haocheng; Bianco, Piero R et al. (2007) DNA helicase activity of PcrA is not required for the displacement of RecA protein from DNA or inhibition of RecA-mediated strand exchange. J Bacteriol 189:4502-9